首页> 外文期刊>Indian Journal of Endocrinology and Metabolism >Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?
【24h】

Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?

机译:体重指数正常的印度患者的非酒精性脂肪肝疾病的临床病理特征和代谢特征:它们与肥胖或超重的非酒精性脂肪肝疾病有区别吗?

获取原文
           

摘要

Background:Obesity is an important risk factor for non-alcoholic fatty liver disease (NAFLD); however, NAFLD does occur in lean subjects. This study was aimed to evaluate the magnitude, clinical, pathological, and metabolic profiles of NAFLD in normal body mass index (BMI) subjects (defined as lean NAFLD) in comparison to overweight or obese NAFLD and lean healthy control.Materials and Methods:336 subjects (205 consecutive NAFLD, and 131 healthy controls) were studied.Results:Among 205 NAFLD patients, 27 (13.2%) were lean, while 141 (68.8%) and 37 (18%) patients were obese and overweight, respectively. The lean NAFLD compared to obese NAFLD had significantly lesser degree of fasting hyperinsulinemia (P < 0.001), homeostasis model assessment insulin resistance (HOMA-IR, P < 0.001), and lower prevalence of diabetes mellitus (P = 0.01) and metabolic syndrome (P < 0.001). The profiles of serum lipids were similar between all 3 BMI categories, and 89% of lean NAFLD were dyslipidemic. Compared to obese subjects, patients with lean NAFLD had less hepatic necro-inflammation (P = 0.05) and fibrosis (P < 0.001). However, the proportion of steatohepatitis and advanced fibrosis were similar between all BMI categories. The profiles of overweight NAFLD were similar to those of lean NAFLD, except for higher HOMA-IR, uric acids and male gender in overweight group. Despite being lean, the mean BMI of lean NAFLD were still higher than unselected lean healthy controls (P = 0.02).Conclusions:Lean NAFLD patients have less severe disease, minor, or no insulin resistance, but are frequently dyslipidemic and have BMI higher than lean healthy control.
机译:背景:肥胖是非酒精性脂肪肝疾病(NAFLD)的重要危险因素;但是,NAFLD确实发生在瘦弱的受试者中。这项研究的目的是评估与体重超重或肥胖的NAFLD和健康的健康对照相比,正常体重指数(BMI)受试者(定义为瘦NAFLD)中NAFLD的大小,临床,病理和代谢特征。材料和方法:336结果:205名NAFLD患者中,有27名(13.2%)是瘦的,而141名(68.8%)和37名(18%)是肥胖和超重的。与肥胖NAFLD相比,瘦NAFLD的空腹高胰岛素血症程度(P <0.001),体内稳态模型评估的胰岛素抵抗(HOMA-IR,P <0.001)显着更低,糖尿病的患病率(P = 0.01)和代谢综合征(P P <0.001)。在所有三个BMI类别之间,血清脂质的分布相似,并且89%的瘦NAFLD具有血脂异常。与肥胖受试者相比,瘦NAFLD患者的肝坏死性炎症(P = 0.05)和纤维化(P <0.001)较少。然而,所有BMI类别之间脂肪性肝炎和晚期纤维化的比例相似。超重NAFLD的特征与瘦NAFLD相似,不同之处在于超重组的HOMA-IR,尿酸和男性性别较高。尽管较瘦,但NAFLD的平均BMI仍高于未选择的瘦健康对照组(P = 0.02)。结论:瘦NAFLD患者的病情较轻,轻度或无胰岛素抵抗,但常有血脂异常和BMI高于精益健康控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号